High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018
ABSTRACTHuman papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic disparities in cervical cancer incidence and mortality in the United States are well documented. HPV vaccination has been recommended in the United States since 2006 and is expected to prevent HPV-attribut...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2308378 |
| _version_ | 1797302940948496384 |
|---|---|
| author | Ruth Stefanos Rayleen M. Lewis Troy D. Querec Julia W. Gargano Elizabeth R. Unger Lauri E. Markowitz |
| author_facet | Ruth Stefanos Rayleen M. Lewis Troy D. Querec Julia W. Gargano Elizabeth R. Unger Lauri E. Markowitz |
| author_sort | Ruth Stefanos |
| collection | DOAJ |
| description | ABSTRACTHuman papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic disparities in cervical cancer incidence and mortality in the United States are well documented. HPV vaccination has been recommended in the United States since 2006 and is expected to prevent HPV-attributable cancers in all racial/ethnic groups. Quadrivalent HPV vaccine-type (HPV6/11/16/18) and nonvaccine-type cervicovaginal HPV prevalences were estimated from National Health and Nutrition Examination Surveys in 2015–2018 (vaccine era) and 2003–2006 (prevaccine era) data. Prevalence ratios comparing 2015–2018 to 2003–2006 were calculated among sexually experienced Non-Hispanic White (NHW), Non-Hispanic Black (NHB), and Mexican American (MA) females aged 14–24 years. Quadrivalent HPV vaccine-type prevalence declined 82% (CI: 60%–92%) among NHW, 86% (CI: 64%–95%) among NHB, and 100% among MA females, forecasting future reductions in cervical cancer across racial/ethnic groups. |
| first_indexed | 2024-03-07T23:46:09Z |
| format | Article |
| id | doaj.art-62ff273db71d4854a01578c2ae178415 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-07T23:46:09Z |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-62ff273db71d4854a01578c2ae1784152024-02-19T12:09:41ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2308378High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018Ruth Stefanos0Rayleen M. Lewis1Troy D. Querec2Julia W. Gargano3Elizabeth R. Unger4Lauri E. Markowitz5Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USADivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USADivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USADivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USADivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USADivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAABSTRACTHuman papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic disparities in cervical cancer incidence and mortality in the United States are well documented. HPV vaccination has been recommended in the United States since 2006 and is expected to prevent HPV-attributable cancers in all racial/ethnic groups. Quadrivalent HPV vaccine-type (HPV6/11/16/18) and nonvaccine-type cervicovaginal HPV prevalences were estimated from National Health and Nutrition Examination Surveys in 2015–2018 (vaccine era) and 2003–2006 (prevaccine era) data. Prevalence ratios comparing 2015–2018 to 2003–2006 were calculated among sexually experienced Non-Hispanic White (NHW), Non-Hispanic Black (NHB), and Mexican American (MA) females aged 14–24 years. Quadrivalent HPV vaccine-type prevalence declined 82% (CI: 60%–92%) among NHW, 86% (CI: 64%–95%) among NHB, and 100% among MA females, forecasting future reductions in cervical cancer across racial/ethnic groups.https://www.tandfonline.com/doi/10.1080/21645515.2024.2308378HPV vaccinecervical cancerrace/ethnicityNational Health and Nutrition Examination Surveyadolescents and young adult females |
| spellingShingle | Ruth Stefanos Rayleen M. Lewis Troy D. Querec Julia W. Gargano Elizabeth R. Unger Lauri E. Markowitz High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 Human Vaccines & Immunotherapeutics HPV vaccine cervical cancer race/ethnicity National Health and Nutrition Examination Survey adolescents and young adult females |
| title | High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 |
| title_full | High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 |
| title_fullStr | High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 |
| title_full_unstemmed | High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 |
| title_short | High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 |
| title_sort | high impact of quadrivalent human papillomavirus vaccine across racial ethnic groups national health and nutrition examination survey 2003 2006 and 2015 2018 |
| topic | HPV vaccine cervical cancer race/ethnicity National Health and Nutrition Examination Survey adolescents and young adult females |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2308378 |
| work_keys_str_mv | AT ruthstefanos highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 AT rayleenmlewis highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 AT troydquerec highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 AT juliawgargano highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 AT elizabethrunger highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 AT lauriemarkowitz highimpactofquadrivalenthumanpapillomavirusvaccineacrossracialethnicgroupsnationalhealthandnutritionexaminationsurvey20032006and20152018 |